Bio-Rad’s QX600 Droplet Digital PCR System advancing measurable residual disease research
Bio-Rad Laboratories is accelerating measurable residual disease (MRD) research through more than a half dozen collaborations with institutions and companies leveraging its new QX600 Droplet Digital PCR System. Launched late last year, it boasts six color detection capable of quantifying 12 targets per well, a simple user workflow, and powerful data analysis. Maintaining Bio-Rad’s ddPCR technology, this platform utilizes the same droplet generation and processing protocols as the QX200 system, enabling thousands of current customers to easily adopt its advanced multiplexing capabilities.
The introduction of the QX600 ddPCR System expands the company’s family of QX platforms, which currently includes the CE Marked IVDR compliant QX200 system, the FDA-cleared QXDx system; and the high-throughput, fully automated QX ONE system.
